Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Talking to an expert on T1D and COVID-19

.page-title {
display: none;
}
h1 {
font-family: Arial Black;
font-size: 50px;
}

.grey-box-two{
width:68%;
padding-left:24px;
padding-right:16px;
padding-top:10px;
padding-bottom:10px;
margin-right:24px;
margin-bottom:20px;
background:#ffffff;
min-width: ;
border: ;
}

@media screen and (max-width: 600px) {
.grey-box-two {
width:100%;
}
}

Talking to an expert on T1D and COVID-19

 

April 22, 2020

A Q & A with Dr. Rémi Rabasa-Lhoret, JDRF-funded clinical scientist and endocrinologist at the Institut de recherches cliniques de Montréal

JDRF invited leading type 1 diabetes (T1D) expert to discuss the probability of contracting COVID-19, who is at greatest risk of getting severely ill, and what people with well-controlled T1D should do to stay healthy.

Dr. Rabasa-Lhoret shared this information and more during our Facebook Live Q & A event, which you can watch below. 

 

 

Dr. Rabasa-Lhoret also answered several live questions from the audience. We share the top themes below.

Q. Are people living with T1D at greater risk of getting infected by COVID-19?

A. No evidence suggests that at this time. Of course, should you already have T1D-related complications, it is easier to contract an infection of any kind.

Q. Are people living with T1D who work in the health care system at risk of contracting COVID-19? Should they take specific precautions?

A. The level of risk is dependent on several factors including the individual’s age, his/her degree of blood glucose control and whether he/she has T1D-related complications. Yet as generally advised, social distancing, washing hands frequently and staying at home remain best practices for these people. As well, they should postpone all clinical visits and get in touch with their health care team whether by phone or online for regular follow-ups.

Dr. Rémi Rabasa-Lhoret 

Q. Is there a worse prognosis for people living with T1D who get COVID-19?

A. We know that the consequences of a viral infection may be more significant among people with T1D as it can lead to uncontrolled blood sugar. Yet the prognosis depends on several factors including the individual’s age, his/her current degree of blood glucose control and whether he/she has a pre-existing T1D-related condition like heart disease and/or kidney disease.

Q. Is there a specific risk for contracting COVID-19 among children with T1D?

 A. We have not seen any reports with major or bad outcomes for children with T1D who have been infected with COVID-19. Even when the disease has manifested, it was extremely mild. However, blood sugar control needs to be carefully monitored in such cases and families should be prepared with extra supplies like insulin and ketone strips.

Q. Is there any risk for supply issues among companies that manufacture insulin and CGM materials?

A. At this time, all companies have stock and we anticipate no disruption in the supply chain.

Q. Which medications are safe to use?

A. Acetaminophens, like Tylenol, can be used as a first-line treatment. However, they are not anti-inflammatory and people with T1D should know these medications can sometimes interfere with certain CGMs, etc. Should you already be taking Ibuprofen (ex. Advil) for another condition such as arthritis, it is recommended to continue doing so following consultation with your health care practitioner.

For more info on T1D and COVID-19 please visit breakthrought1d.ca/coronavirus.

 

Sign up for our newsletter and stay connected